首页> 外国专利> Discrete imaging of hepatic oxidative and nitrosative stress with two-channel nanoparticles for in vivo drug safety screening

Discrete imaging of hepatic oxidative and nitrosative stress with two-channel nanoparticles for in vivo drug safety screening

机译:使用两通道纳米颗粒的肝脏氧化和亚硝化应激离散成像,用于体内药物安全性筛选

摘要

Encompassed are embodiments of activatable nanoprobes useful for in vivo longitudinal imaging of drug hepatotoxicity with oxidative and nitrosative stress as the safety biomarkers. Both H2O2 and ONOOare important mediators of radical stress. Two channels of optical detection, intrinsically free from cross-talk, were engineered into superconducting polymer nanoparticles to generate chemiluminescence resonance energy transfer between the conjugated polymer matrix of the nanoparticle and an incorporated chemiluminescent substrate allowing for the luminescent detection of H2O2 and fluorescence resonance energy transfer between the polymer matrix and an oxidation-degradable fluorophore for ratiometric detection of ONOO These nanoprobes have been applied for real-time in vivo monitoring of hepatotoxicity resulting from challenges from drugs. In addition to the ability of imaging the dose-dependence of oxidative and nitrosative stress, the positive detection of radical stress that precedes histological changes allow the early and longitudinal detection of drug-induced hepatotoxicity in vivo.
机译:包括用于以氧化和亚硝化应激作为安全生物标记物的药物肝毒性的体内纵向成像的可活化纳米探针的实施方案。 H 2 O 2 和ONOO -都是自由基应力的重要介体。将两个本来没有串扰的光学检测通道设计到超导聚合物纳米颗粒中,以在纳米颗粒的共轭聚合物基质和掺入的化学发光底物之间产生化学发光共振能量转移,从而实现H <2 / Sub> O 2 以及聚合物基体和可氧化降解的荧光团之间的荧光共振能量转移,用于ONOO的比例检测。这些纳米探针已被用于实时体内监测肝毒性,该肝毒性来自于毒品。除了可以对氧化应激和亚硝化应激的剂量依赖性进行成像之外,在组织学变化之前对自由基应激的阳性检测还可以在体内早期和纵向检测药物引起的肝毒性。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号